Details for Patent: 7,622,130

« Back to Dashboard

Which drugs does patent 7,622,130 protect, and when does it expire?

Patent 7,622,130 protects KYBELLA and is included in one NDA.

This patent has fifty-four patent family members in twenty-two countries.

Summary for Patent: 7,622,130

Title:	Methods and compositions for the non-surgical removal of fat
Abstract:	Compositions and methods useful in the non-surgical removal of localized fat deposits in patients in need thereof using pharmacologically active detergents are disclosed. The pharmacologically active detergent compositions can additionally include anti-inflammatory agents, analgesics, dispersion agents and pharmaceutically acceptable excipients but do not contain phosphotidylcholine. The pharmacologically active detergent compositions are useful for treating localized accumulations of fat including lower eyelid fat herniation, lipodystrophy and fat deposits associated with cellulite and do not require surgical procedures such as liposuction.
Inventor(s):	Kolodney; Michael S. (Santa Monica, CA), Rotunda; Adam M. (Los Angeles, CA)
Assignee:	Los Angeles Biomedical Research Institute at Harbor UCLA-Medical Center (Torrance, CA) The Regents of the University of California (Oakland, CA)
Application Number:	11/054,171
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 7,622,130
Prior Art and Litigation Support	Order Prior Art and Litigation support for Patent 7,622,130
Patent Claim Types: see list of patent claims	Use; Composition;

Drugs Protected by US Patent 7,622,130

Glossary

Subscribe to access the full database, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Kythera Biopharms	KYBELLA	deoxycholic acid	SOLUTION;SUBCUTANEOUS	206333-001	Apr 29, 2015		RX	Yes	Yes	➤ Sign Up	➤ Sign Up				METHOD FOR REDUCTION OF SUBMENTAL FAT	➤ Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate

International Family Members for US Patent 7,622,130

Subscribe to access the full database, or try a Free Trial
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Austria	518565	➤ Sign Up
Austria	521355	➤ Sign Up
Australia	2005245002	➤ Sign Up
Canada	2567298	➤ Sign Up
China	101018553	➤ Sign Up
China	105233287	➤ Sign Up
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

By using our website you are consenting to our use of cookies in accordance with our privacy policy.